1st Quarter Ended 30 June 2007 | ||||||||||||||||
Key Information | Three Months Ended 30 June | |||||||||||||||
2007 US$M | 2006 US$M | Movement | ||||||||||||||
Net Sales From Ordinary Activities |
424.4 | 415.5 | up | 2 | % | |||||||||||
Operating Profit From Operations After Tax
Attributable to Shareholders |
39.1 | 35.5 | up | 10 | % | |||||||||||
Net Tangible Assets per Ordinary Share |
US$ | 0.32 | US$ | 0.24 | up | 33 | % |
Contents |
||
1.
|
Media Release | |
2. 3. 4.
|
Managements Analysis of Results | |
Condensed Consolidated Financial Statements | ||
Management Presentation |
For media enquiries please call Peter Baker on: | ||
15 August 2007
|
Tel: (02) 8274 5304 | |
For analyst enquiries please call Steve Ashe on: | ||
Tel: (02) 8274 5246 Mob: 0408 164 011. |
1
US$ Million | Q1 | Q1 | % Change | |||||||||
FY 2008 | FY 2007 | |||||||||||
Net sales |
$ | 424.4 | $ | 415.5 | 2 | |||||||
Gross profit |
166.9 | 157.7 | 6 | |||||||||
SCI and other related expenses |
| (2.4 | ) | | ||||||||
EBIT excluding asbestos |
105.7 | 96.1 | 10 | |||||||||
AICF SG&A expenses |
(0.6 | ) | | | ||||||||
Asbestos adjustments |
(30.1 | ) | (27.2 | ) | (11 | ) | ||||||
EBIT |
75.0 | 68.9 | 9 | |||||||||
Net interest income (expense) |
0.5 | (2.0 | ) | | ||||||||
Income tax expense |
(36.4 | ) | (32.3 | ) | (13 | ) | ||||||
Net operating profit |
39.1 | 35.5 | 10 | |||||||||
Q1 | Q1 | |||||||||||
US$ Million | FY 2008 | FY 2007 | % Change | |||||||||
Net operating profit |
$ | 39.1 | $ | 35.5 | 10 | |||||||
Asbestos: |
||||||||||||
Asbestos adjustments |
30.1 | 27.2 | 11 | |||||||||
AICF SG&A expenses |
0.6 | | | |||||||||
AICF interest income |
(1.6 | ) | | | ||||||||
Tax expense related to asbestos adjustments |
0.4 | | | |||||||||
Net operating profit excluding asbestos |
$ | 68.6 | $ | 62.7 | 9 |
2
3
US$ Million | Q1 | Q1 | ||||||
FY 2008 | FY 2007 | |||||||
Effect of foreign exchange |
$ | (33.2 | ) | $ | (27.2 | ) | ||
Other adjustments |
3.1 | | ||||||
Asbestos adjustments to EBIT |
$ | (30.1 | ) | $ | (27.2 | ) | ||
4
Telephone:
|
61 2 8274 5246 | |
Mobile:
|
61 408 164 011 | |
Email:
|
[email protected] | |
Facsimile:
|
61 2 8274 5218 |
5
6
US$ Millions | Q1 | Q1 | ||||||
FY 2008 | FY 2007 | |||||||
EBIT |
$ | 75.0 | $ | 68.9 | ||||
Asbestos: |
||||||||
Asbestos adjustments |
30.1 | 27.2 | ||||||
AICF SG&A expenses |
0.6 | | ||||||
EBIT excluding asbestos |
$ | 105.7 | $ | 96.1 | ||||
Net Sales |
$ | 424.4 | $ | 415.5 | ||||
EBIT margin excluding asbestos |
24.9 | % | 23.1 | % | ||||
US$ Millions | Q1 | Q1 | ||||||
FY 2008 | FY 2007 | |||||||
Net operating profit |
$ | 39.1 | $ | 35.5 | ||||
Asbestos: |
||||||||
Asbestos adjustments |
30.1 | 27.2 | ||||||
AICF SG&A expenses |
0.6 | | ||||||
AICF interest income |
(1.6 | ) | | |||||
Tax expense related to asbestos adjustments |
0.4 | | ||||||
Net operating profit excluding asbestos |
$ | 68.6 | $ | 62.7 | ||||
US$ Millions (except share data) | Q1 | Q1 | ||||||
FY 2008 | FY 2007 | |||||||
Net operating profit excluding asbestos |
$ | 68.6 | $ | 62.7 | ||||
Weighted average common shares outstanding Diluted (millions) |
469.4 | 466.9 | ||||||
Diluted earnings per share excluding asbestos (US cents) |
14.6 | 13.4 | ||||||
7
US$ Millions | Q1 | Q1 | ||||||
FY 2008 | FY 2007 | |||||||
Operating profit before income taxes |
$ | 75.5 | $ | 66.9 | ||||
Asbestos: |
||||||||
Asbestos adjustments |
30.1 | 27.2 | ||||||
AICF SG&A expenses |
0.6 | | ||||||
AICF interest income |
(1.6 | ) | | |||||
Operating profit before income taxes excluding asbestos |
$ | 104.6 | $ | 94.1 | ||||
Income tax expense |
$ | 36.4 | $ | 32.3 | ||||
Asbestos: |
||||||||
Tax expense related to asbestos adjustments |
(0.4 | ) | | |||||
Income tax expense excluding asbestos |
$ | 36.0 | $ | 32.3 | ||||
Effective tax rate excluding asbestos |
34.4 | % | 34.3 | % | ||||
US$ Millions | Q1 | Q1 | ||||||
FY 2008 | FY 2007 | |||||||
EBIT |
$ | 75.0 | $ | 68.9 | ||||
Depreciation and amortisation |
14.2 | 11.0 | ||||||
EBITDA |
$ | 89.2 | $ | 79.9 | ||||
8
| expectations about the timing and amount of payments to the Asbestos Injuries Compensation Fund (AICF), a special purpose fund for the compensation of proven asbestos-related personal injury and death claims; | |
| expectations with respect to the effect on our financial statements of those payments; | |
| statements as to the possible consequences of proceedings brought against us and certain of our former directors and officers by the Australian Securities and Investments Commission; | |
| expectations that our credit facilities will be extended or renewed; | |
| projections of our operating results or financial condition; | |
| statements regarding our plans, objectives or goals, including those relating to competition, acquisitions, dispositions and our products; | |
| statements about our future performance; and | |
| statements about product or environmental liabilities. |
9
Three Months Ended 30 June | ||||||||||||
US GAAP US$ Millions | ||||||||||||
FY 2008 | FY 2007 | % Change | ||||||||||
Net Sales |
||||||||||||
USA Fibre Cement |
$ | 346.1 | $ | 348.9 | (1 | ) | ||||||
Asia Pacific Fibre Cement |
71.2 | 59.2 | 20 | |||||||||
Other |
7.1 | 7.4 | (4 | ) | ||||||||
Total Net Sales |
$ | 424.4 | $ | 415.5 | 2 | |||||||
Cost of goods sold |
(257.5 | ) | (257.8 | ) | | |||||||
Gross profit |
166.9 | 157.7 | 6 | |||||||||
Selling, general and administrative expenses |
(55.5 | ) | (51.7 | ) | (7 | ) | ||||||
Research & development expenses |
(6.3 | ) | (7.5 | ) | 16 | |||||||
SCI and other related expenses |
| (2.4 | ) | | ||||||||
Asbestos adjustments |
(30.1 | ) | (27.2 | ) | (11 | ) | ||||||
EBIT |
75.0 | 68.9 | 9 | |||||||||
Net interest income (expense) |
0.5 | (2.0 | ) | | ||||||||
Operating profit before income taxes |
75.5 | 66.9 | 13 | |||||||||
Income tax expense |
(36.4 | ) | (32.3 | ) | (13 | ) | ||||||
Operating profit before cumulative effect
of change in accounting principle |
39.1 | 34.6 | 13 | |||||||||
Cumulative effect of change in accounting
principle for stock-based compensation, net
of income tax expense of nil and US$0.4
million, respectively |
| 0.9 | | |||||||||
Net operating profit |
$ | 39.1 | $ | 35.5 | 10 | |||||||
Earnings per share diluted (US cents) |
8.3 | 7.6 | 9 | |||||||||
Volume (mmsf) |
||||||||||||
USA Fibre Cement |
573.4 | 605.7 | (5 | ) | ||||||||
Asia Pacific Fibre Cement |
98.0 | 91.8 | 7 | |||||||||
Average net sales price per unit (per msf) |
||||||||||||
USA Fibre Cement |
US$ | 604 | US$ | 576 | 5 | |||||||
Asia Pacific Fibre Cement |
A$ | 873 | A$ | 862 | 1 | |||||||
1
2
3
4
US$ Million | Q1 FY 2008 | Q1 FY 2007 | ||||||
Effect of foreign exchange |
$ | (33.2 | ) | $ | (27.2 | ) | ||
Other adjustments |
3.1 | | ||||||
Asbestos adjustments |
$ | (30.1 | ) | $ | (27.2 | ) | ||
EBIT - US$ Millions | Three Months Ended 30 June | |||||||||||
FY 2008 | FY 2007 | % Change | ||||||||||
USA Fibre Cement |
$ | 114.4 | $ | 103.3 | 11 | |||||||
Asia Pacific Fibre Cement |
12.4 | 10.3 | 20 | |||||||||
Research & Development |
(4.1 | ) | (4.6 | ) | 11 | |||||||
Other |
(1.3 | ) | (2.7 | ) | 52 | |||||||
General Corporate |
(16.3 | ) | (10.2 | ) | (60 | ) | ||||||
Asbestos adjustments |
(30.1 | ) | (27.2 | ) | (11 | ) | ||||||
EBIT |
75.0 | 68.9 | 9 | |||||||||
Excluding: |
||||||||||||
Asbestos: |
||||||||||||
Asbestos adjustments |
30.1 | 27.2 | 11 | |||||||||
AICF SG&A expenses |
0.6 | | | |||||||||
EBIT excluding asbestos |
$ | 105.7 | $ | 96.1 | 10 | |||||||
Net sales |
$ | 424.4 | $ | 415.5 | 2 | |||||||
EBIT margin excluding asbestos |
24.9 | % | 23.1 | % | ||||||||
5
6
Net Operating Profit - US$ Millions | Three Months Ended 30 June | |||||||||||
FY 2008 | FY 2007 | % Change | ||||||||||
Net operating profit |
$ | 39.1 | $ | 35.5 | 10 | |||||||
Excluding: |
||||||||||||
Asbestos: |
||||||||||||
Asbestos adjustments |
30.1 | 27.2 | 11 | |||||||||
Tax expense related to asbestos adjustments |
0.4 | | | |||||||||
AICF SG&A costs |
0.6 | | | |||||||||
AICF interest income |
(1.6 | ) | | | ||||||||
Net operating profit excluding asbestos |
$ | 68.6 | $ | 62.7 | 9 | |||||||
7
At 30 June 2007 | ||||||||||||
Effective Interest | ||||||||||||
Description | Rate | Total Facility | Principal Drawn | |||||||||
(US$ millions) |
||||||||||||
364-day facilities,
can be drawn in US$, variable interest
rates based on LIBOR plus margin, can be
repaid and redrawn until June 2008 |
5.81 | % | $ | 110.0 | $ | 60.0 | ||||||
Term facilities, can be drawn in US$,
variable interest rates based on
LIBOR plus margin, can be repaid and
redrawn until June 2010 |
5.99 | % | 245.0 | 65.0 | ||||||||
Total |
$ | 355.0 | $ | 125.0 | ||||||||
8
Telephone:
|
61 2 8274 5246 | |
Mobile:
|
61 0408 164 011 | |
Email:
|
[email protected] | |
Facsimile:
|
61 2 8274 5218 |
9
10
US$ Millions | Q1 | Q1 | ||||||
FY 2008 | FY 2007 | |||||||
EBIT |
$ | 75.0 | $ | 68.9 | ||||
Asbestos: |
||||||||
Asbestos adjustments |
30.1 | 27.2 | ||||||
AICF SG&A expenses |
0.6 | | ||||||
EBIT excluding asbestos |
$ | 105.7 | $ | 96.1 | ||||
Net Sales |
$ | 424.4 | $ | 415.5 | ||||
EBIT margin excluding asbestos |
24.9 | % | 23.1 | % | ||||
US$ Millions | Q1 | Q1 | ||||||
FY 2008 | FY 2007 | |||||||
Net operating profit |
$ | 39.1 | $ | 35.5 | ||||
Asbestos: |
||||||||
Asbestos adjustments |
30.1 | 27.2 | ||||||
AICF SG&A expenses |
0.6 | | ||||||
AICF interest income |
(1.6 | ) | | |||||
Tax expense related to asbestos adjustments |
0.4 | | ||||||
Net operating profit excluding asbestos |
$ | 68.6 | $ | 62.7 | ||||
US$ Millions (except share data) | Q1 | Q1 | ||||||
FY 2008 | FY 2007 | |||||||
Net operating profit excluding asbestos |
$ | 68.6 | $ | 62.7 | ||||
Weighted average common shares outstanding Diluted (millions) |
469.4 | 466.9 | ||||||
Diluted earnings per share excluding asbestos (US cents) |
14.6 | 13.4 | ||||||
11
Q1 | Q1 | |||||||
US$ Millions | FY 2008 | FY 2007 | ||||||
Operating profit before income taxes |
$ | 75.5 | $ | 66.9 | ||||
Asbestos: |
||||||||
Asbestos adjustments |
30.1 | 27.2 | ||||||
AICF SG&A expenses |
0.6 | | ||||||
AICF interest income |
(1.6 | ) | | |||||
Operating profit before income taxes excluding asbestos |
$ | 104.6 | $ | 94.1 | ||||
Income tax expense |
$ | 36.4 | $ | 32.3 | ||||
Asbestos: |
||||||||
Tax expense related to asbestos adjustments |
(0.4 | ) | | |||||
Income tax expense excluding asbestos |
$ | 36.0 | $ | 32.3 | ||||
Effective tax rate excluding asbestos |
34.4 | % | 34.3 | % | ||||
Q1 | Q1 | |||||||
US$ Millions | FY 2008 | FY 2007 | ||||||
EBIT |
$ | 75.0 | $ | 68.9 | ||||
Depreciation and amortisation |
14.2 | 11.0 | ||||||
EBITDA |
$ | 89.2 | $ | 79.9 | ||||
12
13
Total Fibre | ||||||||||||
Cement | ||||||||||||
Operations | ||||||||||||
- excluding | ||||||||||||
Asbestos | Asbestos | |||||||||||
US$ Million | Compensation | Compensation | As Reported | |||||||||
ASSETS |
||||||||||||
Current assets: |
||||||||||||
Cash and cash equivalents |
$ | 227.5 | $ | (146.9 | ) | $ | 80.6 | |||||
Restricted cash and cash equivalents |
5.0 | 144.7 | 149.7 | |||||||||
Accounts and notes receivable, net of
allowance for doubtful accounts of $1.4m |
168.0 | 0.2 | 168.2 | |||||||||
Inventories |
133.6 | | 133.6 | |||||||||
Prepaid expenses and other current assets |
48.2 | 0.3 | 48.5 | |||||||||
Insurance receivable Asbestos |
| 9.9 | 9.9 | |||||||||
Workers compensation Asbestos |
| 2.9 | 2.9 | |||||||||
Deferred income taxes |
18.5 | | 18.5 | |||||||||
Deferred income taxes Asbestos |
| 9.4 | 9.4 | |||||||||
Total current assets |
600.8 | 20.5 | 621.3 | |||||||||
Property, plant and equipment, net |
839.2 | 0.4 | 839.6 | |||||||||
Insurance receivable Asbestos |
| 167.5 | 167.5 | |||||||||
Workers compensation Asbestos |
| 80.5 | 80.5 | |||||||||
Deferred income taxes |
2.3 | | 2.3 | |||||||||
Deferred income taxes Asbestos |
| 330.8 | 330.8 | |||||||||
Deposit with Australian Taxation Office |
173.7 | | 173.7 | |||||||||
Other assets |
2.1 | | 2.1 | |||||||||
Total assets |
$ | 1,618.1 | $ | 599.7 | $ | 2,217.8 | ||||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||||||
Current liabilities: |
||||||||||||
Accounts payable and accrued liabilities |
$ | 124.7 | $ | 1.1 | $ | 125.8 | ||||||
Short-term debt |
60.0 | | 60.0 | |||||||||
Dividends payable |
70.7 | | 70.7 | |||||||||
Accrued payroll and employee benefits |
37.9 | 0.1 | 38.0 | |||||||||
Accrued product warranties |
6.7 | | 6.7 | |||||||||
Income taxes payable |
37.9 | (11.8 | ) | 26.1 | ||||||||
Asbestos liability |
| 66.8 | 66.8 | |||||||||
Workers compensation Asbestos |
| 2.9 | 2.9 | |||||||||
Other liabilities |
14.0 | | 14.0 | |||||||||
Total current liabilities |
351.9 | 59.1 | 411.0 | |||||||||
Long-term debt |
65.0 | | 65.0 | |||||||||
Deferred income taxes |
93.8 | | 93.8 | |||||||||
Accrued product warranties |
9.8 | | 9.8 | |||||||||
Asbestos liability |
| 1,272.0 | 1,272.0 | |||||||||
Workers compensation Asbestos |
| 80.5 | 80.5 | |||||||||
Other liabilities |
134.3 | 3.7 | 138.0 | |||||||||
Total liabilities |
654.8 | 1,415.3 | 2,070.1 | |||||||||
Commitments and contingencies |
||||||||||||
Shareholders equity |
||||||||||||
Common stock |
252.1 | | 252.1 | |||||||||
Additional paid-in capital |
183.8 | | 183.8 | |||||||||
Retained earnings (Accumulated deficit) |
514.9 | (815.6 | ) | (300.7 | ) | |||||||
Accumulated other comprehensive income |
12.5 | | 12.5 | |||||||||
Total shareholders equity |
963.3 | (815.6 | ) | 147.7 | ||||||||
Total liabilities and shareholders equity |
$ | 1,618.1 | $ | 599.7 | $ | 2,217.8 | ||||||
14
Total Fibre | ||||||||||||
Cement | ||||||||||||
Operations | ||||||||||||
- excluding | ||||||||||||
Asbestos | Asbestos | |||||||||||
US$ Million | Compensation | Compensation | As Reported | |||||||||
Net Sales |
||||||||||||
USA Fibre Cement |
$ | 346.1 | | $ | 346.1 | |||||||
Asia Pacific Fibre Cement |
71.2 | | 71.2 | |||||||||
Other |
7.1 | | 7.1 | |||||||||
Total Net Sales |
424.4 | | 424.4 | |||||||||
Cost of goods sold |
(257.5 | ) | | (257.5 | ) | |||||||
Gross profit |
166.9 | | 166.9 | |||||||||
Selling, general and administrative expenses |
(54.9 | ) | (0.6 | ) | (55.5 | ) | ||||||
Research and development expenses |
(6.3 | ) | | (6.3 | ) | |||||||
Asbestos adjustments |
| (30.1 | ) | (30.1 | ) | |||||||
EBIT |
105.7 | (30.7 | ) | 75.0 | ||||||||
Net interest (expense) income |
(1.1 | ) | 1.6 | 0.5 | ||||||||
Operating profit (loss) before income taxes |
104.6 | (29.1 | ) | 75.5 | ||||||||
Income tax expense |
(36.0 | ) | (0.4 | ) | (36.4 | ) | ||||||
Net Operating Profit (Loss) |
$ | 68.6 | $ | (29.5 | ) | $ | 39.1 | |||||
15
Total Fibre | ||||||||||||
Cement | ||||||||||||
Operations | ||||||||||||
- excluding | ||||||||||||
Asbestos | Asbestos | |||||||||||
US $ Million | Compensation | Compensation | As Reported | |||||||||
Cash Flows From Operating Activities |
||||||||||||
Net income (loss) |
$ | 68.6 | $ | (29.5 | ) | $ | 39.1 | |||||
Adjustments to reconcile net income (loss) to net
cash provided by operating activities: |
||||||||||||
Depreciation and amortisation |
14.2 | | 14.2 | |||||||||
Deferred income taxes |
11.7 | | 11.7 | |||||||||
Prepaid pension cost |
0.4 | | 0.4 | |||||||||
Stock-based compensation |
1.5 | | 1.5 | |||||||||
Asbestos adjustments |
| 30.1 | 30.1 | |||||||||
Deposit with Australian Taxation Office |
(1.0 | ) | | (1.0 | ) | |||||||
Other |
(0.2 | ) | (0.6 | ) | (0.8 | ) | ||||||
Changes in operating assets and liabilities: |
||||||||||||
Restricted cash and cash equivalents |
| 10.7 | 10.7 | |||||||||
Accounts and notes receivable |
(2.8 | ) | 0.3 | (2.5 | ) | |||||||
Insurance receivable |
| 6.2 | 6.2 | |||||||||
Inventories |
16.0 | | 16.0 | |||||||||
Prepaid expenses and other current assets |
(15.8 | ) | 0.2 | (15.6 | ) | |||||||
Accounts payable and accrued liabilities |
21.2 | | 21.2 | |||||||||
Asbestos liability |
| (17.2 | ) | (17.2 | ) | |||||||
Other accrued liabilities and other liabilities |
17.7 | (0.2 | ) | 17.5 | ||||||||
Net cash provided by operating activities |
$ | 131.5 | | $ | 131.5 | |||||||
Cash Flows From Investing Activities |
||||||||||||
Purchases of property, plant and equipment |
(16.5 | ) | | (16.5 | ) | |||||||
Net cash used in investing activities |
$ | (16.5 | ) | | $ | (16.5 | ) | |||||
Cash Flows From Financing Activities |
||||||||||||
Repayments of short-term borrowings |
(23.0 | ) | | (23.0 | ) | |||||||
Repayments of long-term borrowings |
(40.0 | ) | | (40.0 | ) | |||||||
Proceeds from issuance of shares |
2.2 | | 2.2 | |||||||||
Tax benefit from stock options exercised |
0.2 | | 0.2 | |||||||||
Net cash used in financing activities |
$ | (60.6 | ) | | $ | (60.6 | ) | |||||
Effects of exchange rate changes on cash |
(7.9 | ) | | (7.9 | ) | |||||||
Net increase in cash and cash equivalents |
46.5 | | 46.5 | |||||||||
Cash and cash equivalents at beginning of period |
34.1 | | 34.1 | |||||||||
Cash and cash equivalents at end of period |
$ | 80.6 | | $ | 80.6 | |||||||
Components of Cash and Cash Equivalents |
||||||||||||
Cash at bank and on hand |
$ | 32.7 | | $ | 32.7 | |||||||
Short-term deposits |
47.9 | | 47.9 | |||||||||
Cash and cash equivalents at end of period |
$ | 80.6 | | $ | 80.6 | |||||||
16
| expectations about the timing and amount of payments to the Asbestos Injuries Compensation Fund (AICF), a special purpose fund for the compensation of proven asbestos-related personal injury and death claims; | |
| expectations with respect to the effect on our financial statements of those payments; | |
| statements as to the possible consequences of proceedings brought against us and certain of our former directors and officers by the Australian Securities and Investments Commission; | |
| expectations that our credit facilities will be extended or renewed; | |
| projections of our operating results or financial condition; | |
| statements regarding our plans, objectives or goals, including those relating to competition, acquisitions, dispositions and our products; | |
| statements about our future performance; and | |
| statements about product or environmental liabilities. |
17
Page | ||||
Item 1. Condensed Consolidated Financial Statements (Unaudited) |
||||
Condensed Consolidated Balance Sheets as of 30 June 2007 and 31 March 2007 |
F-3 | |||
Condensed Consolidated Statements of Operations for the Three Months Ended
30 June 2007 and 2006 |
F-4 | |||
Condensed Consolidated Statements of Cash Flows for the Three Months Ended
30 June 2007 and 2006 |
F-6 | |||
Condensed Consolidated Statements of Changes in Shareholders Equity for the
Three Months Ended 30 June 2007 |
F-8 | |||
Notes to Condensed Consolidated Financial Statements |
F-9 | |||
Item 2. Quantitative and Qualitative Disclosures About Market Risk |
F-26 |
F-2
(Millions of | (Millions of | |||||||||||||||
US dollars) | Australian dollars) | |||||||||||||||
30 June | 31 March | 30 June | 31 March | |||||||||||||
2007 | 2007 | 2007 | 2007 | |||||||||||||
Assets |
||||||||||||||||
Current assets: |
||||||||||||||||
Cash and cash equivalents |
$ | 80.6 | $ | 34.1 | A$ | 95.0 | A$ | 42.3 | ||||||||
Restricted cash and cash equivalents |
149.7 | 151.9 | 176.4 | 188.3 | ||||||||||||
Accounts and notes receivable, net of allowance for
doubtful accounts of $1.4 million (A$1.6 million) and
$1.5 million (A$1.9 million) as of 30 June 2007
and 31 March 2007, respectively |
168.2 | 163.4 | 198.2 | 202.5 | ||||||||||||
Inventories |
133.6 | 147.6 | 157.4 | 183.0 | ||||||||||||
Prepaid expenses and other current assets |
48.5 | 32.4 | 57.1 | 40.2 | ||||||||||||
Insurance receivable Asbestos |
9.9 | 9.4 | 11.7 | 11.7 | ||||||||||||
Workers compensation Asbestos |
2.9 | 2.7 | 3.4 | 3.3 | ||||||||||||
Deferred income taxes |
18.5 | 27.3 | 21.8 | 33.8 | ||||||||||||
Deferred income taxes Asbestos |
9.4 | 7.8 | 11.1 | 9.7 | ||||||||||||
Total current assets |
621.3 | 576.6 | 732.1 | 714.8 | ||||||||||||
Property, plant and equipment, net |
839.6 | 827.7 | 989.2 | 1,025.9 | ||||||||||||
Insurance receivable Asbestos |
167.5 | 165.1 | 197.3 | 204.6 | ||||||||||||
Workers compensation Asbestos |
80.5 | 76.5 | 94.8 | 94.8 | ||||||||||||
Deferred income taxes |
2.3 | 6.9 | 2.7 | 8.6 | ||||||||||||
Deferred income taxes Asbestos |
330.8 | 318.2 | 389.7 | 394.4 | ||||||||||||
Deposit with Australian Taxation Office |
173.7 | 154.8 | 204.7 | 191.9 | ||||||||||||
Other assets |
2.1 | 2.3 | 2.5 | 2.9 | ||||||||||||
Total assets |
$ | 2,217.8 | $ | 2,128.1 | A$ | 2,613.0 | A$ | 2,637.9 | ||||||||
Liabilities and Shareholders Equity |
||||||||||||||||
Current liabilities: |
||||||||||||||||
Accounts payable and accrued liabilities |
$ | 125.8 | $ | 100.8 | A$ | 148.2 | A$ | 124.9 | ||||||||
Short-term debt |
60.0 | 83.0 | 70.7 | 102.9 | ||||||||||||
Dividends payable |
70.7 | | 83.3 | | ||||||||||||
Accrued payroll and employee benefits |
38.0 | 42.0 | 44.8 | 52.1 | ||||||||||||
Accrued product warranties |
6.7 | 5.7 | 7.9 | 7.1 | ||||||||||||
Income taxes payable |
26.1 | 10.6 | 30.8 | 13.1 | ||||||||||||
Asbestos liability |
66.8 | 63.5 | 78.7 | 78.7 | ||||||||||||
Workers compensation Asbestos |
2.9 | 2.7 | 3.4 | 3.3 | ||||||||||||
Other liabilities |
14.0 | 9.3 | 16.5 | 11.5 | ||||||||||||
Total current liabilities |
411.0 | 317.6 | 484.3 | 393.6 | ||||||||||||
Long-term debt |
65.0 | 105.0 | 76.6 | 130.1 | ||||||||||||
Deferred income taxes |
93.8 | 93.8 | 110.5 | 116.3 | ||||||||||||
Accrued product warranties |
9.8 | 9.5 | 11.5 | 11.8 | ||||||||||||
Asbestos liability |
1,272.0 | 1,225.8 | 1,498.7 | 1,519.4 | ||||||||||||
Workers compensation Asbestos |
80.5 | 76.5 | 94.8 | 94.8 | ||||||||||||
Other liabilities |
138.0 | 41.2 | 162.6 | 51.1 | ||||||||||||
Total liabilities |
2,070.1 | 1,869.4 | A$ | 2,439.0 | A$ | 2,317.1 | ||||||||||
Commitments and contingencies (Note 7) |
||||||||||||||||
Shareholders equity: |
||||||||||||||||
Common stock, Euro 0.59 par value, 2.0 billion
shares authorised; 467,695,751 shares issued
and outstanding at 30 June 2007 and
467,295,391 shares issued and outstanding
at 31 March 2007 |
252.1 | 251.8 | ||||||||||||||
Additional paid-in capital |
183.8 | 180.2 | ||||||||||||||
Accumulated deficit |
(300.7 | ) | (178.7 | ) | ||||||||||||
Accumulated other comprehensive income |
12.5 | 5.4 | ||||||||||||||
Total shareholders equity |
147.7 | 258.7 | ||||||||||||||
Total liabilities and shareholders equity |
$ | 2,217.8 | $ | 2,128.1 | ||||||||||||
F-3
Three Months | ||||||||
Ended 30 June | ||||||||
(Millions of US dollars, except per share data) | 2007 | 2006 | ||||||
Net sales |
$ | 424.4 | $ | 415.5 | ||||
Cost of goods sold |
(257.5 | ) | (257.8 | ) | ||||
Gross profit |
166.9 | 157.7 | ||||||
Selling, general and administrative expenses |
(55.5 | ) | (51.7 | ) | ||||
Research and development expenses |
(6.3 | ) | (7.5 | ) | ||||
SCI and other related expenses |
| (2.4 | ) | |||||
Asbestos adjustments |
(30.1 | ) | (27.2 | ) | ||||
Operating income |
75.0 | 68.9 | ||||||
Interest expense |
(1.3 | ) | (5.6 | ) | ||||
Interest income |
1.8 | 3.6 | ||||||
Income before income taxes |
75.5 | 66.9 | ||||||
Income tax expense |
(36.4 | ) | (32.3 | ) | ||||
Income before cumulative effect of change
in accounting principle |
39.1 | 34.6 | ||||||
Cumulative effect of change in accounting principle
for stock-based compensation, net of income tax
expense of nil and $0.4 million, respectively |
| 0.9 | ||||||
Net income |
$ | 39.1 | $ | 35.5 | ||||
Net income per share basic |
$ | 0.08 | $ | 0.08 | ||||
Net income per share diluted |
$ | 0.08 | $ | 0.08 | ||||
Weighted average common shares outstanding
(Millions): |
||||||||
Basic |
467.4 | 463.3 | ||||||
Diluted |
469.4 | 466.9 |
F-4
Three Months | ||||||||
Ended 30 June | ||||||||
(Millions of Australian dollars, except per share data) | 2007 | 2006 | ||||||
Net sales |
A$ | 510.3 | A$ | 556.1 | ||||
Cost of goods sold |
(309.6 | ) | (345.0 | ) | ||||
Gross profit |
200.7 | 211.1 | ||||||
Selling, general and administrative expenses |
(66.7 | ) | (69.2 | ) | ||||
Research and development expenses |
(7.6 | ) | (10.0 | ) | ||||
SCI and other related expenses |
| (3.2 | ) | |||||
Asbestos adjustments |
(36.2 | ) | (36.4 | ) | ||||
Operating income |
90.2 | 92.3 | ||||||
Interest expense |
(1.6 | ) | (7.5 | ) | ||||
Interest income |
2.2 | 4.8 | ||||||
Income before income taxes |
90.8 | 89.6 | ||||||
Income tax expense |
(43.8 | ) | (43.3 | ) | ||||
Income before cumulative effect of change
in accounting principle |
47.0 | 46.3 | ||||||
Cumulative effect of change in accounting principle
for stock-based compensation, net of income tax
expense of nil and A$0.5 million, respectively |
| 1.2 | ||||||
Net income |
A$ | 47.0 | A$ | 47.5 | ||||
Net income per share basic |
A$ | 0.10 | A$ | 0.10 | ||||
Net income per share diluted |
A$ | 0.10 | A$ | 0.10 | ||||
Weighted average common shares outstanding
(Millions): |
||||||||
Basic |
467.4 | 463.3 | ||||||
Diluted |
469.4 | 466.9 |
F-5
Three Months | ||||||||
Ended 30 June | ||||||||
(Millions of US dollars) | 2007 | 2006 | ||||||
Cash Flows From Operating Activities |
||||||||
Net income |
$ | 39.1 | $ | 35.5 | ||||
Adjustments to reconcile net income to net cash
provided by operating activities: |
||||||||
Depreciation and amortisation |
14.2 | 11.0 | ||||||
Deferred income taxes |
11.7 | 9.0 | ||||||
Prepaid pension cost |
0.4 | 0.7 | ||||||
Stock-based compensation |
1.5 | 0.2 | ||||||
Asbestos adjustments |
30.1 | 27.2 | ||||||
Cumulative effect of change in accounting principle |
| (0.9 | ) | |||||
Deposit with Australian Taxation Office |
(1.0 | ) | | |||||
Other |
(0.8 | ) | | |||||
Changes in operating assets and liabilities: |
||||||||
Restricted cash and cash equivalents |
10.7 | | ||||||
Accounts and notes receivable |
(2.5 | ) | (3.9 | ) | ||||
Insurance receivable |
6.2 | | ||||||
Inventories |
16.0 | (12.2 | ) | |||||
Prepaid expenses and other current assets |
(15.6 | ) | (5.5 | ) | ||||
Accounts payable and accrued liabilities |
21.2 | (3.9 | ) | |||||
Asbestos liability |
(17.2 | ) | | |||||
Other accrued liabilities and other liabilities |
17.5 | 3.5 | ||||||
Net cash provided by operating activities |
131.5 | 60.7 | ||||||
Cash Flows From Investing Activities |
||||||||
Purchases of property, plant and equipment |
(16.5 | ) | (35.5 | ) | ||||
Net cash used in investing activities |
(16.5 | ) | (35.5 | ) | ||||
Cash Flows From Financing Activities |
||||||||
Repayments of short-term borrowings |
(23.0 | ) | (44.0 | ) | ||||
Repayments of long-term borrowings |
(40.0 | ) | (121.7 | ) | ||||
Proceeds from issuance of shares |
2.2 | 0.2 | ||||||
Tax benefit from stock options exercised |
0.2 | | ||||||
Net cash used in financing activities |
(60.6 | ) | (165.5 | ) | ||||
Effects of exchange rate changes on cash |
(7.9 | ) | 0.6 | |||||
Net increase (decrease) in cash and cash equivalents |
46.5 | (139.7 | ) | |||||
Cash and cash equivalents at beginning of period |
34.1 | 315.1 | ||||||
Cash and cash equivalents at end of period |
$ | 80.6 | $ | 175.4 | ||||
Components of Cash and Cash Equivalents |
||||||||
Cash at bank and on hand |
$ | 32.7 | $ | 23.6 | ||||
Short-term deposits |
47.9 | 151.8 | ||||||
Cash and cash equivalents at end of period |
$ | 80.6 | $ | 175.4 | ||||
F-6
Three Months | ||||||||
Ended 30 June | ||||||||
(Millions of Australian dollars) | 2007 | 2006 | ||||||
Cash Flows From Operating Activities |
||||||||
Net income |
A$ | 47.0 | A$ | 47.5 | ||||
Adjustments to reconcile net income to net cash
provided by operating activities: |
||||||||
Depreciation and amortisation |
17.1 | 14.7 | ||||||
Deferred income taxes |
14.1 | 12.0 | ||||||
Prepaid pension cost |
0.5 | 0.9 | ||||||
Stock-based compensation |
1.8 | 0.3 | ||||||
Asbestos adjustments |
36.2 | 36.5 | ||||||
Cumulative effect of change in accounting principle |
| (1.3 | ) | |||||
Deposit with Australian Taxation Office |
(1.2 | ) | | |||||
Other |
(1.0 | ) | | |||||
Changes in operating assets and liabilities: |
||||||||
Restricted cash and cash equivalents |
12.9 | | ||||||
Accounts and notes receivable |
(2.9 | ) | | |||||
Insurance receivable |
7.5 | (5.2 | ) | |||||
Inventories |
19.2 | (16.3 | ) | |||||
Prepaid expenses and other current assets |
(18.8 | ) | (7.4 | ) | ||||
Accounts payable and accrued liabilities |
25.5 | (5.2 | ) | |||||
Asbestos liability |
(20.7 | ) | | |||||
Other accrued liabilities and other liabilities |
21.0 | 4.7 | ||||||
Net cash provided by operating activities |
158.2 | 81.2 | ||||||
Cash Flows From Investing Activities |
||||||||
Purchases of property, plant and equipment |
(19.8 | ) | (47.6 | ) | ||||
Net cash used in investing activities |
(19.8 | ) | (47.6 | ) | ||||
Cash Flows From Financing Activities |
||||||||
Repayments of short-term borrowings |
(27.7 | ) | (58.9 | ) | ||||
Repayments of long-term borrowings |
(48.1 | ) | (162.9 | ) | ||||
Proceeds from issuance of shares |
2.6 | 0.3 | ||||||
Tax benefit from stock options exercised |
0.2 | | ||||||
Net cash used in financing activities |
(73.0 | ) | (221.5 | ) | ||||
Effects of exchange rate changes on cash |
(12.7 | ) | (16.4 | ) | ||||
Net increase (decrease) in cash and cash equivalents |
52.7 | (204.3 | ) | |||||
Cash and cash equivalents at beginning of period |
42.3 | 440.4 | ||||||
Cash and cash equivalents at end of period |
A$ | 95.0 | A$ | 236.1 | ||||
Components of Cash and Cash Equivalents |
||||||||
Cash at bank and on hand |
A$ | 38.5 | A$ | 31.7 | ||||
Short-term deposits |
56.5 | 204.4 | ||||||
Cash and cash equivalents at end of period |
A$ | 95.0 | A$ | 236.1 | ||||
F-7
(Millions of US dollars) | Accumulated | |||||||||||||||||||
Additional | Other | |||||||||||||||||||
Common | Paid-in | Accumulated | Comprehensive | |||||||||||||||||
Stock | Capital | Deficit | Income | Total | ||||||||||||||||
Balances as of 31 March 2007 |
$ | 251.8 | $ | 180.2 | $ | (178.7 | ) | $ | 5.4 | $ | 258.7 | |||||||||
Comprehensive income: |
||||||||||||||||||||
Net income |
| | 39.1 | | 39.1 | |||||||||||||||
Pension and post-retirement benefit adjustments |
| | | (0.2 | ) | (0.2 | ) | |||||||||||||
Foreign currency translation gain |
| | | 7.3 | 7.3 | |||||||||||||||
Other comprehensive income |
| | | 7.1 | 7.1 | |||||||||||||||
Total comprehensive income |
46.2 | |||||||||||||||||||
Adoption of FIN 48 |
| | (90.4 | ) | | (90.4 | ) | |||||||||||||
Stock-based compensation |
| 1.5 | | | 1.5 | |||||||||||||||
Tax benefit from stock options exercised |
| 0.2 | | | 0.2 | |||||||||||||||
Stock options exercised |
0.3 | 1.9 | | | 2.2 | |||||||||||||||
Dividends payable |
| | (70.7 | ) | | (70.7 | ) | |||||||||||||
Balances as of 30 June 2007 |
$ | 252.1 | $ | 183.8 | $ | (300.7 | ) | $ | 12.5 | $ | 147.7 | |||||||||
F-8
Nature of Operations The Company manufactures and sells fibre cement building products for interior and exterior building construction applications primarily in the United States, Australia, New Zealand, Philippines and Europe. |
|||
Basis of Presentation The condensed consolidated financial statements represent the financial position, results of operations and cash flows of James Hardie Industries N.V. (JHI NV) and its current wholly owned subsidiaries and special interest entities, collectively referred to as either the Company or James Hardie and JHI NV together with its subsidiaries as of the time relevant to the applicable reference, the James Hardie Group, unless the context indicates otherwise. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, included in the Companys Annual Report on Form 20-F for the fiscal year ended 31 March 2007. |
|||
The condensed consolidated financial statements included herein are unaudited; however, they contain all normal recurring adjustments which, in the opinion of the Companys management, are necessary to state fairly the consolidated financial position of the Company at 30 June 2007, and the consolidated results of operations and the consolidated cash flows for the three months ended 30 June 2007 and 2006. The results of operations for the three months ended 30 June 2007 are not necessarily indicative of the results to be expected for the full year. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. | |||
The assets, liabilities, statements of operations and statements of cash flows of the Company have been presented with accompanying Australian dollar (A$) convenience translations as the majority of the Companys shareholder base is Australian. These A$ convenience translations are not prepared in accordance with accounting principles generally accepted in the United States of America. The exchange rates used to calculate the convenience translations are as follows: |
31 March | 30 June | |||||||||||
(US$1 = A$) | 2007 | 2007 | 2006 | |||||||||
Assets and liabilities |
1.2395 | 1.1782 | 1.3463 | |||||||||
Statements of operations |
n/a | 1.2024 | 1.3383 | |||||||||
Cash flows beginning cash |
n/a | 1.2395 | 1.3975 | |||||||||
Cash flows ending cash |
n/a | 1.1782 | 1.3463 | |||||||||
Cash flows current period movements |
n/a | 1.2024 | 1.3383 |
Earnings Per Share The Company is required to disclose basic and diluted earnings per share (EPS). Basic EPS is calculated using income divided by the weighted average number of common shares outstanding during the period. Diluted EPS is similar to basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares calculated using the treasury method that would have been outstanding if dilutive potential common shares, such as options, had been exercised. Accordingly, basic and dilutive common shares outstanding used in determining net income per share are as follows: |
F-9
Three Months | ||||||||
Ended 30 June | ||||||||
(Millions of shares) | 2007 | 2006 | ||||||
Basic common shares outstanding |
467.4 | 463.3 | ||||||
Dilutive effect of stock options |
2.0 | 3.6 | ||||||
Diluted common shares outstanding |
469.4 | 466.9 | ||||||
(US dollars) | 2007 | 2006 | ||||||
Net income per share basic |
$ | 0.08 | $ | 0.08 | ||||
Net income per share diluted |
$ | 0.08 | $ | 0.08 |
Potential common shares of nil and 6.5 million for the three months ended 30 June 2007 and 2006, respectively, have been excluded from the calculations of diluted common shares outstanding because the effect of their inclusion would be anti-dilutive. | |||
Advertising The Company expenses the production costs of advertising the first time the advertising takes place. Advertising expense was US$4.0 million and US$4.3 million for the three months ended 30 June 2007 and 2006, respectively. |
|||
Stock-Based Compensation The Company recognised stock-based compensation expense (included in selling, general and administrative expenses) of US$1.5 million and US$1.5 million for the three months ended 30 June 2007 and 2006, respectively. The amount for the three months ended 30 June 2006 excludes the forfeiture adjustment of US$1.3 million (US$0.9 million net of tax) which is separately disclosed as Cumulative effect of change in accounting principle for stock-based compensation. The tax benefit related to the forfeiture adjustment was US$0.4 million for the three months ended 30 June 2006. |
|||
Upon adoption of Statement of Financial Accounting Standards (SFAS) No. 123R, Accounting for Stock-Based Compensation, at the beginning of fiscal year 2007, the Company analysed forfeiture rates on all of its 2001 Stock Option Plan grants for which vesting was complete resulting in an estimated weighted average forfeiture rate of 30.7%. Based on this estimated rate, a cumulative adjustment to stock-based compensation expense of US$1.3 million was recorded for the three months ended 30 June 2006. The adjustment is presented on the consolidated statements of operations as a cumulative effect of change in accounting principle (net of income tax). The portion of the cumulative adjustment that relates to USA-based employees caused a reduction in the deferred tax asset previously recorded. For the three months ended 30 June 2006, the amount of the cumulative adjustment related to USA-based employees was US$1.0 million. Therefore, the related USA income tax adjustment was US$0.4 million which was recorded to income tax. | |||
Asbestos Prior to 31 March 2007, the Companys consolidated financial statements included an asbestos provision relating to its anticipated future payments to a Special Purpose Fund (SPF) based on the terms of the Original Final Funding Agreement (Original FFA) entered into on 1 December 2005. |
|||
In February 2007, the shareholders approved the Amended Final Funding Agreement (Amended FFA) entered into on 21 November 2006 to provide long-term funding to the Asbestos Injuries Compensation Fund (AICF), a special purpose fund that provides compensation for Australian-related personal injury claims against certain former subsidiary companies of James Hardie in Australia (being Amaca Pty Ltd (Amaca), Amaba Pty Ltd (Amaba) and ABN 60 Pty Ltd (ABN 60) (the Liable Entities)). |
F-10
Amaca and Amaba separated from the James Hardie Group in February 2001. ABN 60 separated from the James Hardie Group in March 2003. Upon shareholder approval of the Amended FFA in February 2007, shares in the Liable Entities were transferred to the AICF. The Company appoints three of the AICF directors and the NSW state government appoints two of the AICF directors. The AICF manages Australian asbestos-related personal injury claims made against the Liable Entities, and makes compensation payments in respect of those proven claims. | |||
AICF Under the terms of the Amended FFA, James Hardie 117 Pty Ltd (the Performing Subsidiary) has a contractual liability to make payments to the AICF. This funding to the AICF results in the Company having a pecuniary interest in the AICF. The interest is considered variable because the potential impact on the Company will vary based upon the annual actuarial assessments obtained by the Company with respect to asbestos-related personal injury claims against the Liable Entities. Due to the Companys variable interest in the AICF, it consolidates the AICF in accordance with Financial Accounting Standards Board (FASB) Interpretation No. 46R, Consolidation of Variable Interest Entities. |
|||
The AICF has operating costs that are claims related and non-claims related. Claims related costs incurred by the AICF are treated as reductions to the accrued asbestos liability balances previously reflected in the consolidated balance sheets. Non-claims related operating costs incurred by the AICF are included in the line item Selling, general and administrative expenses in the consolidated statements of operations. The AICF earns interest on its cash and cash equivalents, these amounts are included in the line item Interest income in the consolidated statements of operations. | |||
Asbestos-Related Assets and Liabilities The Company has recorded on its consolidated balance sheets certain assets and liabilities under the terms of the Amended FFA. These items are Australian dollar-denominated and are subject to translation into US dollars at each reporting date. These assets and liabilities are commonly referred to by the Company as Asbestos-Related Assets and Liabilities and include: |
|||
Asbestos Liability The amount of the asbestos liability reflects the terms of the Amended FFA and has been calculated by reference to (but is not exclusively based upon) the most recent actuarial estimate of projected future cash flows prepared by KPMG Actuaries Pty Ltd (KPMG Actuaries). The asbestos liability includes these cash flows as undiscounted and uninflated on the basis that it is inappropriate to discount or inflate future cash flows when the timing and amounts of such cash flows are not fixed or readily determinable. The asbestos liability also includes an allowance for the future claims-handling costs of the AICF. |
|||
Adjustments in the asbestos liability due to changes in the actuarial estimate of projected future cash flows and changes in the estimate of future operating costs of the AICF are reflected in the consolidated statements of operations during the period in which they occur. Claims paid by the AICF and claims-handling costs incurred by the AICF are treated as reductions in the accrued balances previously reflected in the consolidated balance sheets. | |||
Insurance Receivable There are various insurance policies and insurance companies with exposure to the asbestos claims. The insurance receivable determined by KPMG Actuaries reflect the recoveries expected from all such policies based on the expected pattern of claims against such policies less an allowance for credit risk based on credit agency ratings. The insurance receivable includes these cash flows as undiscounted and uninflated on the basis that it is inappropriate to discount or inflate future cash flows when the timing and amounts of such cash flows are not fixed or readily determinable. The Company only records insurance receivable that it deems to be probable. |
F-11
Included in insurance receivable is US$13.8 million shown on a discounted basis because the timing of the recoveries has been agreed with the insurer. | |||
Adjustments in insurance receivable due to changes in the actuarial estimate, or changes in the Companys assessment of recoverability are reflected in the consolidated statements of operations during the period in which they occur. Insurance recoveries are treated as a reduction in the insurance receivable balance. | |||
Workers Compensation Workers compensation claims are claims made by former employees of the Liable Entities. Such past, current and future reported claims were insured with various insurance companies and the various Australian State-based workers compensation schemes (collectively workers compensation schemes or policies). An estimate of the liability related to workers compensation claims is prepared by KPMG Actuaries as part of the annual actuarial assessment. This estimate contains two components, amounts that will be met by a workers compensation scheme or policy, and amounts that will be met by the Liable Entities. |
|||
The portion of the KPMG Actuaries estimate that is expected to be met by the Liable Entities is included as part of the Asbestos Liability. Adjustments to this estimate are reflected in the consolidated statements of operations during the period in which they occur. | |||
The portion of the KPMG Actuaries estimate that is expected to be met by the workers compensation schemes or policies of the Liable Entities is recorded by the Company as a workers compensation liability. Since these amounts are expected to be met by the workers compensation schemes or policies, the Company records an equivalent workers compensation receivable. Adjustments to the workers compensation liability result in an equal adjustment in the workers compensation receivable recorded by the Company and have no effect on the consolidated statements of operations. | |||
Asbestos-Related Research and Education Contributions The Company has agreed to fund asbestos-related research and education initiatives for a period of 10 years, beginning in fiscal year 2007. The liabilities related to these agreements are included in Other Liabilities on the consolidated balance sheets. |
|||
Restricted Cash Assets of the AICF Cash and cash equivalents of the AICF are reflected as restricted assets, as the use of these assets is restricted to the settlement of asbestos claims and payment of the operating costs of the AICF. |
|||
AICF Other Assets and Liabilities Other assets and liabilities of the AICF, including fixed assets, trade receivables and payables are included on the consolidated balance sheets under the appropriate captions and their use is restricted to the operations of the AICF. |
|||
Deferred Income Taxes The Performing Subsidiary is able to claim a taxation deduction for its contributions to the AICF over a five-year period from the date of contribution. Consequently, a deferred tax asset has been recognised equivalent to the anticipated tax benefit over the life of the Amended FFA. |
|||
Adjustments are made to the deferred income tax asset as adjustments to the asbestos-related assets and liabilities are recorded. |
F-12
Foreign Currency Translation The asbestos-related assets and liabilities are denominated in Australian dollars and thus the reported value of these asbestos-related assets and liabilities in the Companys consolidated balance sheets in US dollars are subject to adjustment depending on the closing exchange rate between the two currencies at the balance sheet date. The effect of foreign exchange rate movements between these currencies is included in Asbestos Adjustments in the consolidated statements of operations. |
|||
Income Taxes In June 2006, the FASB issued FASB Interpretation No. 48 (FIN 48), Accounting for Uncertainty in Income Taxes, an interpretation of SFAS No. 109, Accounting for Income Taxes. FIN 48 clarifies the accounting for uncertainty in income taxes recognised in an enterprises financial statements in accordance with SFAS No. 109. Unlike SFAS No. 109, FIN 48 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Additionally, FIN 48 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. |
|||
The Company adopted FIN 48 on 1 April 2007. The adoption of FIN 48 resulted in the reduction of the Companys consolidated beginning retained earnings of US$90.4 million. As of the adoption date, the Company had US$39.0 million of gross unrecognised tax benefits that if recognised would affect the effective tax rate. As of the adoption date, the Companys opening accrual for interest and penalties is US$52.1 million. | |||
During the three months ended 30 June 2007, the gross increase in unrecognised tax benefits as a result of tax positions taken during a prior period was US$1.5 million. There was also an unfavourable US$2.0 million impact of changes in foreign currency exchange rates. If recognised, US$40.5 million, of the 30 June 2007 balance would affect the effective tax rate. | |||
The Company recognises penalties and interest accrued related to unrecognised tax benefits in income tax expense. During the three months ended 30 June 2007, the Company recognised a US$0.9 million increase in interest and penalties and recognised this amount as income tax expense. There was also an unfavourable impact of changes in foreign currency exchange rates of US$2.7 million. At 30 June 2007, the accrual for interest and penalties is US$55.7 million. | |||
The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, and various states and foreign jurisdictions including Australia and the Netherlands. The Company is no longer subject to U.S. federal examinations by U.S. Internal Revenue Service (IRS) for tax years prior to tax year 2004. The Company is no longer subject to examinations by the Netherlands tax authority, the Belastingdienst, for tax years prior to tax year 2002. With certain limited exceptions, the Company is no longer subject to Australian federal examinations by the Australian Taxation Office (ATO) for tax years prior to tax year 2000. The Company is currently subject to audit and review in a number of jurisdictions in which it operates and has been advised that further audits will commence in the next 12 months. It is anticipated that the audits and reviews currently being conducted will be completed within the next 12 months. | |||
A number of years may elapse before an uncertain tax position is audited and ultimately settled. It is difficult to predict the ultimate outcome or the timing of resolution for uncertain tax positions. It is reasonably possible that the amount of unrecognised tax benefits could significantly increase or decrease within the next twelve months. These changes could result from the settlement of ongoing litigation, the completion of ongoing examinations, the expiration of the statute of limitations, or other circumstances. At this time, an estimate of the range of the reasonably possible change cannot be made. |
F-13
Recent Accounting Pronouncements | |||
Fair Value Option for Financial Assets and Financial Liabilities In February 2007, the FASB issued Statement No. 159, The Fair Value Option for Financial Assets and Financial Liabilities (SFAS No. 159), which allows for voluntary measurement of financial assets and liabilities as well as certain other items at fair value. Unrealised gains and losses on financial instruments for which the fair value option has been elected are reported in earnings. The provisions of SFAS No. 159 are effective for the Company on 1 April 2008, and it is currently evaluating the impact on its financial statements of adopting SFAS No. 159. |
Inventories consist of the following components: |
30 June | 31 March | |||||||
(Millions of US dollars) | 2007 | 2007 | ||||||
Finished goods |
$ | 86.8 | $ | 101.5 | ||||
Work-in-process |
15.8 | 12.3 | ||||||
Raw materials and supplies |
37.2 | 37.8 | ||||||
Provision for obsolete finished goods and raw materials |
(6.2 | ) | (4.0 | ) | ||||
Total inventories |
$ | 133.6 | $ | 147.6 | ||||
The Company has reported its operating segment information in the format that the operating segment information is available to and evaluated by the Board of Directors. USA Fibre Cement manufactures and sells fibre cement interior linings, exterior siding and related accessories products in the United States. Asia Pacific Fibre Cement includes all fibre cement manufactured in Australia, New Zealand and the Philippines and sold in Australia, New Zealand and Asia. Research and Development represents the cost incurred by the research and development centres. Other includes the manufacture and sale of fibre cement reinforced pipes in the United States, fibre cement operations in Europe and roofing operations in the United States. The roofing plant was closed and the business ceased operations in April 2006. The Companys operating segments are strategic operating units that are managed separately due to their different products and/or geographical location. |
F-14
The following are the Companys operating segments and geographical information: | |||
Operating Segments |
Net Sales to Customers | ||||||||
Three Months | ||||||||
Ended 30 June | ||||||||
(Millions of US dollars) | 2007 | 2006 | ||||||
USA Fibre Cement |
$ | 346.1 | $ | 348.9 | ||||
Asia Pacific Fibre Cement |
71.2 | 59.2 | ||||||
Other |
7.1 | 7.4 | ||||||
Worldwide total |
$ | 424.4 | $ | 415.5 | ||||
Income Before Income Taxes | ||||||||
Three Months | ||||||||
Ended 30 June | ||||||||
(Millions of US dollars) | 2007 | 2006 | ||||||
USA Fibre Cement |
$ | 114.4 | $ | 103.3 | ||||
Asia Pacific Fibre Cement |
12.4 | 10.3 | ||||||
Research and Development |
(4.1 | ) | (4.6 | ) | ||||
Other |
(1.3 | ) | (2.7 | ) | ||||
Segments total |
121.4 | 106.3 | ||||||
General Corporate 1 |
(46.4 | ) | (37.4 | ) | ||||
Total operating income |
75.0 | 68.9 | ||||||
Net interest income 2 |
0.5 | (2.0 | ) | |||||
Worldwide total |
$ | 75.5 | $ | 66.9 | ||||
Total Identifiable Assets | ||||||||
30 June | 31 March | |||||||
(Millions of US dollars) | 2007 | 2007 | ||||||
USA Fibre Cement |
$ | 884.5 | $ | 893.0 | ||||
Asia Pacific Fibre Cement |
206.8 | 199.3 | ||||||
Other |
53.7 | 52.5 | ||||||
Segments total |
1,145.0 | 1,144.8 | ||||||
General Corporate 3 |
1,072.8 | 983.3 | ||||||
Worldwide total |
$ | 2,217.8 | $ | 2,128.1 | ||||
F-15
Net Sales to Customers | ||||||||
Three Months | ||||||||
Ended June 30 | ||||||||
(Millions of US dollars) | 2007 | 2006 | ||||||
USA |
$ | 349.1 | $ | 353.7 | ||||
Australia |
46.8 | 41.0 | ||||||
New Zealand |
17.3 | 12.4 | ||||||
Other Countries |
11.2 | 8.4 | ||||||
Worldwide total |
$ | 424.4 | $ | 415.5 | ||||
Total Identifiable Assets | ||||||||
30 June | 31 March | |||||||
(Millions of US dollars) | 2007 | 2007 | ||||||
USA |
$ | 926.3 | $ | 935.7 | ||||
Australia |
131.3 | 127.1 | ||||||
New Zealand |
24.7 | 23.1 | ||||||
Other Countries |
62.7 | 58.9 | ||||||
Segments total |
1,145.0 | 1,144.8 | ||||||
General Corporate3 |
1,072.8 | 983.3 | ||||||
Worldwide total |
$ | 2,217.8 | $ | 2,128.1 | ||||
1 | Included in General Corporate for the three months ended 30 June 2007 are unfavourable asbestos adjustments of US$30.1 million and AICF SG&A expenses of US$0.6 million. Included in General Corporate for the three months ended 30 June 2006 are unfavourable asbestos adjustments of US$27.2 million. See Note 6. | |
2 | Included in Net Interest Income for the three months ended 30 June 2007 is AICF interest income of US$1.6 million. See Note 6. | |
3 | Asbestos-related assets at 30 June 2007 and 31 March 2007 are $746.6 million and US$727.6 million, respectively, and are included in the General Corporate segment. See Note 6. |
5. | Accumulated Other Comprehensive Income | |
Accumulated other comprehensive income consists of the following components: |
30 June | 31 March | |||||||
(Millions of US dollars) | 2007 | 2007 | ||||||
Pension and post-retirement benefit adjustments
(net of US$1.2 million and US$1.2 million tax benefit, respectively) |
$ | (2.9 | ) | (2.7 | ) | |||
Foreign currency translation adjustments |
15.4 | 8.1 | ||||||
Total accumulated other comprehensive income |
$ | 12.5 | $ | 5.4 | ||||
F-16
6. | Asbestos | |
In February 2007, the Amended FFA was approved to provide long-term funding to the AICF. The accounting policies utilised by the Company to account for the Amended FFA are described in Note 2, Summary of Significant Accounting Policies. |
F-17
(Millions of US dollars) | 2007 | 2006 | ||||||
Effect of foreign exchange |
$ | (33.2 | ) | $ | (27.2 | ) | ||
Other adjustments |
3.1 | | ||||||
Total Asbestos Adjustments |
$ | (30.1 | ) | $ | (27.2 | ) | ||
30 June | 31 March | |||||||
(Millions of US dollars) | 2007 | 2007 | ||||||
Asbestos liability current |
$ | (66.8 | ) | $ | (63.5 | ) | ||
Asbestos liability non-current |
(1,272.0 | ) | (1,225.8 | ) | ||||
Asbestos liability Total |
(1,338.8 | ) | (1,289.3 | ) | ||||
Insurance receivable current |
9.9 | 9.4 | ||||||
Insurance receivable non-current |
167.5 | 165.1 | ||||||
Insurance receivable Total |
177.4 | 174.5 | ||||||
Workers compensation asset current |
2.9 | 2.7 | ||||||
Workers compensation asset non-current |
80.5 | 76.5 | ||||||
Workers compensation liability current |
(2.9 | ) | (2.7 | ) | ||||
Workers compensation liability non-current |
(80.5 | ) | (76.5 | ) | ||||
Workers compensation Total |
| | ||||||
Deferred income taxes current |
9.4 | 7.8 | ||||||
Deferred income taxes non-current |
330.8 | 318.2 | ||||||
Deferred income taxes Total |
340.2 | 326.0 | ||||||
Income tax payable (reduction to income tax payable) |
11.8 | 9.0 | ||||||
Other net liabilities |
(4.0 | ) | (6.3 | ) | ||||
Net Amended FFA liability |
(813.4 | ) | (786.1 | ) | ||||
Restricted cash assets of the AICF |
144.7 | 146.9 | ||||||
Unfunded Net Amended FFA liability |
$ | (668.7 | ) | $ | (639.2 | ) | ||
F-18
A$ | A$ to US$ | US$ Millions | ||||||||||
Millions | rate | |||||||||||
Asbestos liability 31 March 2007 |
A$ | (1,598.1 | ) | 1.2395 | $ | (1,289.3 | ) | |||||
Asbestos claims paid1 |
20.0 | 1.2024 | 16.6 | |||||||||
AICF claims-handling costs incurred1 |
0.7 | 1.2024 | 0.6 | |||||||||
Effect of foreign exchange |
(66.7 | ) | ||||||||||
Asbestos liability 30 June 2007 |
A$ | (1,577.4 | ) | 1.1782 | $ | (1,338.8 | ) | |||||
A$ | A$ to US$ | US$ Millions | ||||||||||
Millions | rate | |||||||||||
Insurance receivable 31 March 2007 |
A$ | 216.3 | 1.2395 | $ | 174.5 | |||||||
Insurance recoveries1 |
(7.5 | ) | 1.2024 | (6.2 | ) | |||||||
Change in estimate2 |
0.2 | 1.1782 | 0.2 | |||||||||
Effect of foreign exchange |
8.9 | |||||||||||
Insurance receivable 30 June 2007 |
A$ | 209.0 | 1.1782 | $ | 177.4 | |||||||
A$ | A$ to US$ | US$ Millions | ||||||||||
Millions | rate | |||||||||||
Deferred income taxes 31 March 2007 |
A$ | 404.1 | 1.2395 | $ | 326.0 | |||||||
Amounts offset against income tax payable1 |
(2.8 | ) | 1.2024 | (2.3 | ) | |||||||
Impact of asbestos adjustments1 |
(0.5 | ) | 1.2024 | (0.4 | ) | |||||||
Effect of foreign exchange |
16.9 | |||||||||||
Deferred income taxes 30 June 2007 |
A$ | 400.8 | 1.1782 | $ | 340.2 | |||||||
F-19
A$ | A$ to US$ | US$ Millions | ||||||||||
Millions | rate | |||||||||||
Restricted cash assets 31 March 2007 |
A$ | 182.1 | 1.2395 | $ | 146.9 | |||||||
Asbestos claims paid1 |
(20.0 | ) | 1.2024 | (16.6 | ) | |||||||
AICF operating costs paid claims-handling1 |
(0.7 | ) | 1.2024 | (0.6 | ) | |||||||
AICF operating costs paid non claims-handling1 |
(0.7 | ) | 1.2024 | (0.6 | ) | |||||||
Insurance recoveries1 |
7.5 | 1.2024 | 6.2 | |||||||||
Interest and investment income1 |
1.9 | 1.2024 | 1.6 | |||||||||
Other1 |
0.4 | 1.2024 | 0.3 | |||||||||
Effect of foreign exchange |
7.5 | |||||||||||
Restricted cash assets 30 June 2007 |
A$ | 170.5 | 1.1782 | $ | 144.7 | |||||||
1 | The average exchange rate for the period is used to convert the Australian dollar amount to US dollars based on the assumption that these transactions occurred evenly throughout the period. | |
2 | The spot exchange rate at 30 June 2007 is used to convert the Australian dollar amount to US dollars as the adjustment to the estimate was made on that date. |
F-20
Three Months | Twelve Months | |||||||
Ended | Ended | |||||||
30 June 2007 | 31 March 2007 | |||||||
Number of claims filed |
155 | 463 | ||||||
Number of claims dismissed |
31 | 121 | ||||||
Number of claims settled or otherwise resolved |
109 | 416 | ||||||
Average settlement amount per settled claim |
A$ | 135,742 | A$ | 166,164 | ||||
Average settlement amount per settled claim |
US$ | 112,893 | US$ | 127,165 |
For the | ||||||||||||||||||||
Period Ended | For the Year Ended 31 March | |||||||||||||||||||
30 June 2007 | 2007 | 2006(1) | 2005 | 2004 | ||||||||||||||||
Number of open claims at beginning of period |
490 | 564 | 712 | 687 | 743 | |||||||||||||||
Number of new claims |
155 | 463 | 346 | 489 | 379 | |||||||||||||||
Number of closed claims |
140 | 537 | 502 | 464 | 435 | |||||||||||||||
Number of open claims at end of period |
505 | 490 | 556 | 712 | 687 | |||||||||||||||
Average settlement amount per settled claim |
A$ | 135,742 | A$ | 166,164 | A$ | 151,883 | A$ | 157,594 | A$ | 167,450 | ||||||||||
Average settlement amount per case closed |
A$ | 105,685 | A$ | 128,723 | A$ | 122,535 | A$ | 136,536 | A$ | 121,642 | ||||||||||
Average settlement amount per settled claim |
US$ | 112,893 | US$ | 127,165 | US$ | 114,318 | US$ | 116,572 | US$ | 116,127 | ||||||||||
Average settlement amount per case closed |
US$ | 87,895 | US$ | 98,510 | US$ | 92,229 | US$ | 100,996 | US$ | 84,356 |
(1) | Information includes claims data for only 11 months ended 28 February 2006. Claims data for the 12 months ended 31 March 2006 were not available at the time the Companys financial statements were prepared. |
F-21
7. | Commitments and Contingencies | |
ASIC Proceedings | ||
In February 2007 ASIC announced that it was commencing civil proceedings in the Supreme Court of New South Wales (the Court) against the Company, ABN 60 and ten former officers and directors of the James Hardie Group. While the subject matter of the allegations varies between individual defendants, the allegations against the Company are confined to alleged contraventions of provisions of the Australian Corporations Act/Law relating to continuous disclosure, a directors duty of care and diligence, and engaging in misleading or deceptive conduct in respect of a security. | ||
In the proceedings, ASIC seeks: |
| declarations regarding the alleged contraventions; | ||
| orders for pecuniary penalties in such amount as the Court thinks fit up to the limits specified in the Corporations Act; | ||
| orders that Michael Brown, Michael Gillfillan, Meredith Hellicar, Martin Koffel, Peter Macdonald, Philip Morley, Geoffrey OBrien, Peter Shafron, Gregory Terry and Peter Willcox be prohibited from managing an Australian corporation for such period as the Court thinks fit; | ||
| an order that the Company execute a deed of indemnity in favour of ABN 60 Pty Limited in the amount of A$1.9 billion or such amount as ABN 60 or its directors consider is necessary to ensure that ABN 60 remains solvent; and | ||
| its costs of the proceedings. |
F-22
8. | Short and Long-Term Debt | |
Debt consists of the following components: |
30 June | 31 March | |||||||
(Millions of US dollars) | 2007 | 2007 | ||||||
Short-term debt |
$ | 60.0 | $ | 83.0 | ||||
Long-term debt |
65.0 | 105.0 | ||||||
Total debt1 |
$ | 125.0 | $ | 188.0 | ||||
1 | Total debt at 5.90% and 5.91% weighted average rates at 30 June 2007 and 31 March 2007, respectively. |
F-23
The Company anticipates being able to meet its future payment obligations from existing cash, unutilised committed facilities and future net operating cash flows. | ||
9. | Amended ATO Assessment | |
In March 2006, RCI Pty Ltd (RCI), a wholly owned subsidiary of the Company, received an amended assessment from the ATO in respect of RCIs income tax return for the year ended 31 March 1999. The amended assessment relates to the amount of net capital gains arising as a result of an internal corporate restructure carried out in 1998 and has been issued pursuant to the discretion granted to the Commissioner of Taxation under Part IVA of the Income Tax Assessment Act 1936. The original amended assessment issued to RCI was for a total of A$412.0 million. However, after two remissions of general interest charges (GIC) made by the ATO during fiscal year 2007, the total was revised to A$368.0 million and is comprised of the following as of 30 June 2007: |
(Millions of dollars) | US$ (1) | A$ | ||||||
Primary tax after allowable credits |
$ | 146.0 | A$ | 172.0 | ||||
Penalties (2) |
36.5 | 43.0 | ||||||
GIC |
129.9 | 153.0 | ||||||
Total amended assessment |
$ | 312.4 | A$ | 368.0 | ||||
(1) | US$ amounts calculated using the A$/US$ foreign exchange spot rate at 30 June 2007. | |
(2) | Represents 25% of primary tax. |
F-24
The Company expects that amounts paid in respect of the amended assessment would be recovered by RCI (with interest) at the time RCI is successful in its appeal against the amended assessment. As a result, the Company has treated all payments in respect of the amended assessment that have been made up to 30 June 2007 as a deposit and it is the Companys intention to treat any payments to be made at a later date as a deposit. | ||
10. | Stock-Based Compensation | |
At 30 June 2007, the Company had the following stock-based compensation plans: the Executive Share Purchase Plan; the Managing Board Transitional Stock Option Plan; the JHI NV 2001 Equity Incentive Plan; the JHI NV Stock Appreciation Rights Incentive Plan; the Supervisory Board Share Plan; the Supervisory Board Share Plan 2006 and the Long-Term Incentive Plan. | ||
The following table summarises all of the Companys shares available for grant and the movement in all of the Companys outstanding options: |
Outstanding Options | ||||||||||||
Weighted | ||||||||||||
Shares | Average | |||||||||||
Available for | Exercise | |||||||||||
Grant | Number | Price | ||||||||||
Balance at 1 April 2007 |
19,420,793 | 18,939,817 | A$ | 7.52 | ||||||||
Exercised |
| (400,360 | ) | A$ | 6.51 | |||||||
Forfeited |
504,500 | (504,500 | ) | A$ | 8.05 | |||||||
Balance at 30 June 2007 |
19,925,293 | 18,034,957 | A$ | 7.53 | ||||||||
F-25
US$ | A$ | NZ$ | Other (1) | |||||||||||||
Net sales |
82.3 | % | 11.0 | % | 4.1 | % | 2.6 | % | ||||||||
Cost of goods sold |
83.1 | % | 10.7 | % | 3.7 | % | 2.5 | % | ||||||||
Expenses(2) |
49.0 | % | 45.5 | % | 2.0 | % | 3.5 | % | ||||||||
Liabilities (excluding borrowings)(2) |
15.0 | % | 83.3 | % | 1.0 | % | 0.7 | % |
(1) | Comprises Philippine pesos and Euros. | |
(2) | Liabilities include A$ denominated asbestos liability, which was initially recorded in the fourth quarter of fiscal year 2006. Expenses include adjustments to the liability. See Note 6 for further information. |
F-26
F-27
| expectations about the timing and amount of payments to the Asbestos Injuries Compensation Fund (AICF), a special purpose fund for the compensation of proven asbestos-related personal injury and death claims; | ||
| expectations with respect to the effect on the Companys financial statements of those payments; | ||
| statements as to the possible consequences of proceedings brought against the Company and certain of its former directors and officers by the Australian Securities and Investments Commission; | ||
| expectations that our credit facilities will be extended or renewed; | ||
| projections of the Companys operating results or financial condition; | ||
| statements regarding the Companys plans, objectives or goals, including those relating to competition, acquisitions, dispositions and the Companys products; | ||
| statements about the Companys future performance; and | ||
| statements about product or environmental liabilities. |
F-28
James Hardie FY08 1st Quarter Results 15 August 2007 In this Management Presentation, James Hardie may present financial measures, sales volume terms, financial ratios, and Non-US GAAP financial measures included in the Definitions section of this document starting on page 40. The company presents financial measures that it believes are customarily used by its Australian investors. Specifically, these financial measures include "EBIT", "EBIT margin", "Operating profit" and "Net operating profit". The company may also present other terms for measuring its sales volumes ("million square feet (mmsf)" and "thousand square feet (msf)"); financial ratios ("Gearing ratio", "Net interest expense cover", "Net interest paid cover", "Net debt payback", "Net debt/cash"); and Non-US GAAP financial measures ("EBIT and EBIT margin excluding asbestos", "Net operating profit excluding asbestos", "Diluted earnings per share excluding asbestos", "Operating profit before income taxes excluding asbestos", "Income tax expense excluding asbestos", "Effective tax rate excluding asbestos", and "EBITDA"). Unless otherwise stated, results and comparisons are of the 1st quarter of the current fiscal year versus the 1st quarter of the prior fiscal year. |
Overview and Operating Review - Louis Gries, CEO Financial Review - Russell Chenu, CFO Questions and Answers Agenda |
US$ Million Q1 FY08 Q1 FY07 % Change Net operating profit 39.1 35.5 10 Net operating profit excluding asbestos 68.6 62.7 9 Diluted earnings per share, excluding asbestos (US cents) 14.6 13.4 9 Strong operating performance despite further weakness in major markets Net operating profit affected by asbestos (mostly related to stronger A$) Overview |
1st Quarter USA Fibre Cement - improved market penetration, price growth and cost management helped deliver a very strong EBIT result despite further weakness in US housing Asia Pacific Fibre Cement - both sales and EBIT up despite weak Australian and New Zealand housing and renovation markets Business continued to generate strong operating cash flows Overview |
Operating Review Louis Gries, CEO |
USA Fibre Cement US Coastal Living Idea House, with HardiePlankTM siding |
1st Quarter Result Net Sales down 1% to US$346.1 million Sales Volume down 5% to 573.4 mmsf Average Price up 5% to US$604 per msf EBIT up 11% to US$114.4 million EBIT Margin up 3.5 pts to 33.1% USA Fibre Cement |
1st Quarter Market Conditions Further weakness in new housing construction activity Starts down 22% and 31% for June and March quarters, respectively Market demand affected by affordability issues: Higher interest rates Tighter lending standards (related to subprime mortgage concerns) Inventory levels of new homes for sale are very high Builder confidence levels very low Some softening in repair and remodelling activity USA Fibre Cement |
Key Points Impact of weaker housing market on sales largely offset by: Seasonal order build in anticipation of improved housing demand Market penetration Higher average net sales price Sales volumes of exterior products were lower in Southern and Northern Divisions, but higher in Western Division Within exterior products, sales volumes up for XLD(r) trim and ColorPlus(r) collection Interior products sales volumes were flat Higher raw material prices Margin improvement USA Fibre Cement |
Outlook Housing construction activity to remain weak, with the potential for further deterioration Slight decline in repair and remodelling activity expected in short to mid-term James Hardie will continue investment in growth initiatives Further market penetration against alternative materials USA Fibre Cement |
1 Rolling 12 month average of seasonally adjusted estimate of housing starts by US Census Bureau. USA Fibre Cement Top Line Growth 200 600 1,000 1,400 1,800 2,200 2,600 3,000 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 JH Volume (mmsf), Starts (000's Units) $100 $300 $500 $700 $900 $1,100 $1,300 Revenue (USDM) JH Volume JH Revenue Housing Starts 07 |
USA Fibre Cement Primary Growth Performance - -30% - -20% - -10% 0% 10% 20% 30% Q105 Q205 Q305 Q405 Q106 Q206 Q306 Q406 Q107 Q207 Q307 Q407 Q108 %JHBP Growth (sdft) New Construction/Repair & Remodel Growth Rolling 4Qtr - %JHBP Growth (sdft) Rolling 4Qtr - New Construction/Repair & Remodel Growth |
USA Fibre Cement Average Net Selling Price US$ per MSF 360 380 400 420 440 460 480 500 520 540 560 580 600 620 FY02 FY03 FY04 FY05 FY06 FY07 Q1 FY08 |
Strategy Aggressively grow demand for our products in targeted market segments Grow our overall market position while defending our share in existing market segments Offer products with superior value to that of our competitors, introducing differentiated products to reduce direct price competition USA Fibre Cement |
*Excludes restructuring and other operating expenses of US$12.6 million in Q3 FY02 EBIT and EBIT Margin* USA Fibre Cement 0 20 40 60 80 100 120 140 FY02 FY03 FY04 FY05 FY06 FY07 Q1 FY08 EBIT US$M 0 5 10 15 20 25 30 35 EBIT MARGIN % EBIT EBIT/Sales |
Asia Pacific Fibre Cement Stockland, Rawson Homes and Cosmopolitan Homes at Murrays Beach, Lake Macquarie NSW, featuring a range of ScyonTM products |
1st Quarter Result Net Sales up 20% to US$71.2 million Sales Volume up 7% to 98.0 mmsf EBIT up 20% to US$12.4 million EBIT Margin flat 17.4% Asia Pacific Fibre Cement |
Strategy Grow primary demand for our products Leverage our superior technology to offer differentiated products and systems with superior value to those of competitors Promote a smarter way to build composite construction houses using our products Vigorously defend our position in existing market segments Asia Pacific Fibre Cement |
Key Points Further weakness in new housing and renovations activity in Australia, flat in New Zealand and slightly stronger construction activity in the Philippines US$ financial results assisted by appreciation of Asia Pacific currencies compared with same period last year Net sales up 8% in A$; volumes up 7% due to market share gains; and average sales price up 1% In Australia, growth in fibre cement segment through sales of Scyon(tm) range of products. Non-differentiated products remain subject to strong competitive pressures In New Zealand, sales of Linea(r) weatherboards continued to drive market share growth In the Philippines, net sales up due to increased domestic construction activity and stronger export demand Asia Pacific Fibre Cement |
Outlook Further weakness in new housing and renovations activity in Australia and New Zealand in short-term Further growth in primary demand for fibre cement in Australia and New Zealand Non-differentiated products to remain subject to strong competition More manufacturing efficiencies and other cost savings Construction activity in the Philippines expected to remain healthy in short-term Asia Pacific Fibre Cement |
USA Hardie Pipe Q1 net sales lower due to weaker residential housing activity in Florida Impact of lower volumes partly offset by higher average net sales price and improved manufacturing performance Small EBIT loss for the quarter Europe Fibre Cement Sales continuing to grow steadily Further reduction in EBIT loss Other |
USA Fibre Cement Some further weakness in US housing activity expected through the remainder of 2007 Expect to continue outperforming the market overall Asia Pacific Fibre Cement Market conditions to remain challenging in Australia and New Zealand, but further growth in primary demand for fibre cement expected Overall Outlook for Operations |
Financial Review Russell Chenu, CFO |
Strong Q1 operating performance in significantly weaker market conditions Strong Q1 net operating profit excluding asbestos Asbestos adjustments: US$33.2m - unfavourable impact of stronger A$ on estimated A$ asbestos liability US$3.1m - favourable other adjustments Strong balance sheet excluding net Amended FFA liability Net debt - US$44.4m Cash and unused term facilities - US$310.6m Cash flow cap resulted in no payment to AICF on 1 July 2007, as previously flagged Two-year buffer included in initial payment made February 2007 Next payment due 1 July 2008 Next actuarial estimate as at 31 March 2008 Cash flow cap based on FY08 net operating cash flow Share buy-back announced Overview |
Share buy-back On market buy-back program announced Up to 10% of issued capital (up to approximately 46.8 million shares) Focus on improving efficiency of capital structure Shares to be purchased opportunistically, subject to market conditions and operating environment Additional funding facilities will be sought as required No time period for buy-back has been set |
US$ Million Q1'08 Q1'07 % Change Net sales 424.4 415.5 2 Gross profit 166.9 157.7 6 SG&A expenses (55.5) (51.7) (7) Research & development expenses (6.3) (7.5) 16 SCI and other related expenses - (2.4) - Asbestos adjustments (30.1) (27.2) (11) EBIT 75.0 68.9 9 Net interest income (expense) 0.5 (2.0) - Income tax expense (36.4) (32.3) (13) Effect of change in accounting principle - net of tax - 0.9 - Net operating profit 39.1 35.5 (10) Results - Q1 |
US$ Million Q1'08 Q1'07 % Change Net operating profit 39.1 35.5 10 Asbestos: Asbestos adjustments 30.1 27.2 (11) Tax expense related to asbestos adjustments 0.4 - - AICF SG&A expenses 0.6 - - AICF interest income (1.6) - - Net operating profit excluding asbestos 68.6 62.7 9 Results - Q1 |
US$ Million Q1'08 Q1'07 % Change USA Fibre Cement 346.1 348.9 (1) Asia Pacific Fibre Cement 71.2 59.2 20 Other 7.1 7.4 (4) Total 424.4 415.5 2 Segment Net Sales - Q1 |
US$ Million Q1'08 Q1'07 % Change USA Fibre Cement 114.4 103.3 11 Asia Pacific Fibre Cement 12.4 10.3 20 Other (1.3) (2.7) 52 R & D1 (4.1) (4.6) 11 Total Segment EBIT 121.4 106.3 14 General Corporate excluding asbestos (15.7) (10.2) (54) Total EBIT excluding asbestos 105.7 96.1 10 Asbestos adjustments (30.1) (27.2) (11) AICF SG&A expenses (0.6) - - Total EBIT 75.0 68.9 9 1 R&D includes "core" R&D expenses and administrative expenses, but excludes product development expenses Segment EBIT - Q1 |
US$ Million Q1'08 Q1'07 % Change Stock compensation expenses 1.5 1.5 - Earnings-related bonus 0.9 (1.8) - SCI and other related expenses - 2.4 - Non-US warranty provision 4.0 - - ASIC proceedings 1.2 - - AICF SG&A costs 0.6 - - Other costs 8.1 8.1 - Total 16.3 10.2 60 Corporate Costs - Q1 |
US$ Million Q1'08 Q1'07 Net interest income (expense) 0.5 (2.0) Note - Q1'08 includes US$1.6 million of AICF interest income. Q1'07 includes a US$6.0 million make-whole payment on prepayment of US$ notes in May 2006. Net Interest Expense |
US$ Million Q1'08 Q1'07 Operating income before income taxes 75.5 66.9 Asbestos: Asbestos adjustments 30.1 27.2 AICF SG&A expenses 0.6 - AICF interest income (1.6) - Operating profit before income taxes excluding asbestos 104.6 94.1 Income tax expense 36.4 32.3 Asbestos: Tax expense related to asbestos adjustments (0.4) - Income tax expense excluding asbestos 36.0 32.3 Effective tax rate excluding asbestos 34.4% 34.3% Income tax expense - Q1 |
US$ Million Q1'08 Q1'07 % Change EBIT USA Fibre Cement 114.4 103.3 11 Asia Pacific Fibre Cement 12.4 10.3 20 Other (1.3) (2.7) 52 R & D (4.1) (4.6) 11 General Corporate excluding asbestos (15.7) (10.2) (54) Depreciation and Amortisation USA Fibre Cement 10.8 7.9 37 Asia Pacific Fibre Cement 2.7 2.5 8 Other 0.7 0.6 17 Total EBITDA excluding asbestos 119.9 107.1 12 Asbestos adjustments (30.1) (27.2) (11) AICF SG&A expenses (0.6) - - Total EBITDA 89.2 79.9 12 EBITDA - Q1 |
US$ Million Q1'08 Q1'08 Q1'07 Q1'07 % Change EBIT EBIT 75.0 68.9 9 9 Non-Cash Items Non-Cash Items - Asbestos adjustments - Asbestos adjustments 30.1 27.2 11 11 - Other Non-Cash Items - Other Non-Cash Items 27.0 11.9 - - Net Working Capital Movements Net Working Capital Movements 8.1 (37.2) - - Cash Flow from Operations Cash Flow from Operations 140.2 70.8 98 98 Tax Payments Tax Payments (4.9) (4.5) 9 9 Deposit with ATO Deposit with ATO (1.0) - - - Interest Paid (net) Interest Paid (net) (2.8) (5.6) (50) (50) Net Operating Cash Flow Net Operating Cash Flow 131.5 60.7 - - Purchases of Property, Plant & Equipment Purchases of Property, Plant & Equipment (16.5) (35.5) (54) (54) Equity Issued Equity Issued 2.4 0.2 - - Other Other (7.9) 0.6 - - Movement in Net Cash (Debt) Movement in Net Cash (Debt) 109.5 26.0 - - Net Cash (Debt) - 31 March Net Cash (Debt) - 31 March (153.9) 12.4 - - Net Cash (Debt) - 30 June Net Cash (Debt) - 30 June (44.4) 38.4 - - Cash Flow |
US$ Million Q1'08 Q1'07 % Change USA Fibre Cement 13.9 32.9 58 Asia Pacific Fibre Cement 1.8 2.6 30 Other 0.8 - - Total 16.5 35.5 54 Capital Expenditure - Q1 |
Q1' FY08 FY07 FY06 EPS (Diluted)1 14.6c 47.6c 44.9c Dividend Paid per share - 9.0c 10.0c Return on Shareholders' Funds1 27.3% 24.0% 29.1% Return on Capital Employed2 34.3% 26.6% 28.9% EBIT/ Sales (EBIT margin)2 24.9% 20.7% 18.9% Gearing Ratio1 4.4% 12.8% (1.6)% Net Interest Expense Cover2 96.1x 49.1x - Net Interest Paid Cover2 37.8x 62.5x 80.2x Net Debt Payback3 0.1 yrs 1.9 yrs - 1 Excludes asbestos adjustments, tax expense/benefit related to asbestos adjustments, AICF SG&A expenses and AICF interest income. 2 Excludes asbestos adjustments and AICF SG&A expenses. 3 Excludes payments under the Amended FFA Key Ratios |
Strong overall operating performance for Q1FY08 Strong cash flow generation The company's financial position remains strong Share buy-back announced Results subject to fluctuation in A$ : US$ exchange rate for foreseeable future Summary |
Questions & Answers |
Disclaimer This Management Presentation contains forward-looking statements. We may from time to time make forward-looking statements in our periodic reports filed with or furnished to the United States Securities and Exchange Commission on Forms 20-F and 6-K, in our annual reports to shareholders, in offering circulars and prospectuses, in media releases and other written materials and in oral statements made by our officers, directors or employees to analysts, institutional investors, representatives of the media and others. Examples of forward-looking statements include: expectations about the timing and amount of payments to the Asbestos Injuries Compensation Fund (AICF), a special purpose fund for the compensation of proven asbestos-related personal injury and death claims; expectations with respect to the effect on our financial statements of those payments; statements as to the possible consequences of proceedings brought against us and certain of our former directors and officers by the Australian Securities and Investments Commission; expectations that our credit facilities will be extended or renewed; projections of our operating results or financial condition; statements regarding our plans, objectives or goals, including those relating to competition, acquisitions, dispositions and our products; statements about our future performance; and statements about product or environmental liabilities. Words such as "believe," "anticipate," "plan," "expect," "intend," "target," "estimate," "project," "predict," "forecast," "guideline," "should," "aim" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Forward-looking statements involve inherent risks and uncertainties. We caution you that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements. These factors, some of which are discussed under "Risk Factors" beginning on page 6 of our Form 20-F filed on 6 July 2007 with the Securities and Exchange Commission, include but are not limited to: all matters relating to or arising out of the prior manufacture of products that contained asbestos by current and former James Hardie subsidiaries; required contributions to the AICF and the effect of foreign exchange on the amount recorded in our financial statements as an asbestos liability; compliance with and changes in tax laws and treatments; competition and product pricing in the markets in which we operate; the consequences of product failures or defects; exposure to environmental, asbestos or other legal proceedings; general economic and market conditions; the supply and cost of raw materials; the success of our research and development efforts; our reliance on a small number of product distributors; compliance with and changes in environmental and health and safety laws; risks of conducting business internationally; compliance with and changes in laws and regulations; foreign exchange risks; the successful implementation of new software systems; and the effect of natural disasters. We caution you that the foregoing list of factors is not exhaustive and that other risks and uncertainties may cause actual results to differ materially from those in forward-looking statements. Forward-looking statements speak only as of the date they are made. |
Endnotes This Management Presentation forms part of a package of information about the company's results. It should be read in conjunction with the other parts of this package, including Management's Analysis of Results, a Media Release and a Financial Report. Definitions Financial Measures - US GAAP equivalents EBIT and EBIT Margin - EBIT, as used in this document, is equivalent to the US GAAP measure of operating income. EBIT margin is defined as EBIT as a percentage of net sales. We believe EBIT and EBIT margin to be relevant and useful information as these are the primary measures used by our management to measure the operating profit or loss of our business. EBIT is one of several metrics used by our management to measure the earnings generated from our operations, excluding interest and income tax expenses. Additionally, EBIT is believed to be a primary measure and terminology used by our Australian investors. EBIT and EBIT margin should be considered in addition to, but not as a substitute for, other measures of financial performance reported in accordance with accounting principles generally accepted in the United States of America. EBIT and EBIT margin, as we have defined them, may not be comparable to similarly titled measures reported by other companies. Operating profit - is equivalent to the US GAAP measure of income. Net operating profit - is equivalent to the US GAAP measure of net income. Sales Volumes mmsf - million square feet msf - thousand square feet |
Endnotes Financial Ratios Gearing Ratio - Net debt/cash divided by net debt/cash plus shareholders' equity. Net interest expense cover - EBIT divided by net interest expense. Net interest paid cover - EBIT divided by cash paid during the period for interest, net of amounts capitalised. Net debt payback - Net debt/cash divided by cash flow from operations. Net debt/cash - Short-term and long-term debt less cash and cash equivalents. |
Non-US GAAP Financial Measures EBIT and EBIT margin excluding asbestos - EBIT and EBIT margin excluding asbestos are not measures of financial performance under US GAAP and should not be considered to be more meaningful than EBIT and EBIT margin. James Hardie has included these financial measures to provide investors with an alternative method for assessing its operating results in a manner that is focussed on the performance of its ongoing operations and provides useful information regarding its financial condition and results of operations. The company uses these non-US GAAP measures for the same purposes. US$ Million Q1 FY08 Q1 FY07 EBIT $ 75.0 $ 68.9 Asbestos: Asbestos adjustments 30.1 27.2 AICF SG&A expenses 0.6 - EBIT excluding asbestos $ 105.7 $ 96.1 Net Sales $ 424.4 $ 415.5 EBIT margin excluding asbestos 24.9% 23.1% |
Non-US GAAP Financial Measures (continued) Net operating profit excluding asbestos- Net operating profit excluding asbestos is not a measure of financial performance under US GAAP and should not be considered to be more meaningful than net income. The company has included this financial measure to provide investors with an alternative method for assessing its operating results in a manner that is focussed on the performance of its ongoing operations. The company uses this non-US GAAP measure for the same purposes. US$ Million Q1 FY08 Q1 FY07 Net operating profit $ 39.1 $ 35.5 Asbestos: Asbestos adjustments 30.1 27.2 AICF SG&A expenses 0.6 - AICF interest income (1.6) - Tax expense related to asbestos adjustments 0.4 - Net operating profit excluding asbestos $ 68.6 $ 62.7 |
Non-US GAAP Financial Measures (continued) Diluted earnings per share excluding asbestos - Diluted earnings per share excluding asbestos is not a measure of financial performance under US GAAP and should not be considered to be more meaningful than diluted earnings per share. The company has included this financial measure to provide investors with an alternative method for assessing its operating results in a manner that is focussed on the performance of its ongoing operations. The company's management uses this non-US GAAP measure for the same purposes. US$ Million Q1 FY08 Q1 FY07 Net operating profit excluding asbestos $ 68.6 $ 62.7 Weighted average common shares outstanding - Diluted (millions) 469.4 466.9 Diluted earnings per share excluding asbestos (US cents) 14.6 13.4 |
Non-US GAAP Financial Measures (continued) Effective tax rate excluding asbestos - Effective tax rate excluding asbestos is not a measure of financial performance under US GAAP and should not be considered to be more meaningful than effective tax rate. The company has included this financial measure to provide investors with an alternative method for assessing its operating results in a manner that is focussed on the performance of its ongoing operations. The company's management uses this non-US GAAP measure for the same purposes. US$ Million Q1 FY08 Q1 FY07 Operating profit before income taxes $ 75.5 $ 66.9 Asbestos: Asbestos adjustments 30.1 27.2 AICF SG&A expenses 0.6 - AICF interest income (1.6) - Operating profit before income taxes excluding asbestos $ 104.6 $ 94.1 Income tax expense $ 36.4 $ 32.3 Asbestos: Tax expense related to asbestos adjustments (0.4) - Income tax expense excluding asbestos $ 36.0 $ 32.3 Effective tax rate excluding asbestos 34.4% 34.3% |
Non-US GAAP Financial Measures (continued) EBITDA - is not a measure of financial performance under US GAAP and should not be considered an alternative to, or more meaningful than, income from operations, net income or cash flows as defined by US GAAP or as a measure of profitability or liquidity. Not all companies calculate EBITDA in the same manner as James Hardie has and, accordingly, EBITDA may not be comparable with other companies. The company has included information concerning EBITDA because it believes that this data is commonly used by investors to evaluate the ability of a company's earnings from its core business operations to satisfy its debt, capital expenditure and working capital requirements. US$ Million Q1 FY08 Q1 FY07 EBIT $ 75.0 $ 68.9 Depreciation and amortisation 14.2 11.0 EBITDA $ 89.2 $ 79.9 |
FY08 1st Quarter Results 15 August 2007 In this Management Presentation, James Hardie may present financial measures, sales volume terms, financial ratios, and Non-US GAAP financial measures included in the Definitions section of this document starting on page 40. The company presents financial measures that it believes are customarily used by its Australian investors. Specifically, these financial measures include "EBIT", "EBIT margin", "Operating profit" and "Net operating profit". The company may also present other terms for measuring its sales volumes ("million square feet (mmsf)" and "thousand square feet (msf)"); financial ratios ("Gearing ratio", "Net interest expense cover", "Net interest paid cover", "Net debt payback", "Net debt/cash"); and Non-US GAAP financial measures ("EBIT and EBIT margin excluding asbestos", "Net operating profit excluding asbestos", "Diluted earnings per share excluding asbestos", "Operating profit before income taxes excluding asbestos", "Income tax expense excluding asbestos", "Effective tax rate excluding asbestos", and "EBITDA"). Unless otherwise stated, results and comparisons are of the 1st quarter of the current fiscal year versus the 1st quarter of the prior fiscal year. |